23 November 2026
Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces the results from the first published biomechanical study showing meaningful improvements in rotator cuff repair (RCR) biomechanics using its TENDON SEAM Rotator Cuff Repair System when compared to traditional techniques.1-5,*,**
The study, published in the Muscles, Ligaments and Tendons Journal (MLTJ), analysed biomechanical performance utilizing the TENDON SEAM Rotator Cuff Repair System technique for full-thickness supraspinatus tears. The results obtained in testing in human cadavers were compared to previously published data on knotted and knotless transosseous-equivalent (TOE) constructs using similar protocols to assess relative performance, and demonstrated:
“Smith+Nephew is committed to advancing rotator cuff repair through technologies that truly improve patient experience and outcomes,” said Ryan Majkrzak, Senior Vice President & General Manager, Global Sports Medicine for Smith+Nephew. “The TENDON SEAM System was designed to offer a better biomechanical construct for surgeons performing rotator cuff surgery and advance the standard of care.”
Patrick Connor, MD, FAAOS, FAOA, and Chief of The Sports Medicine Center at OrthoCarolina commented, “The strength and stability of the TENDON SEAM construct has allowed us to adopt a more progressive rehabilitation approach while maintaining confidence in healing outcomes."
Recently acquired by Smith+Nephew, the TENDON SEAM System is a unique rotator cuff repair solution that offers superior load sharing designed to share load across the repaired tendon, offering superior biomechanical strength and performance, which might help protect the repair through the healing period.1-5,*,** The construct features multiple tightly spaced 2x10mm anchors connected by a continuous stitch designed to distribute forces across the repaired tendon with a seam of fixation perpendicular to the direction of load.
To learn more about Smith+Nephew’s TENDON SEAM Rotator Cuff Repair System, please read the full study: Biomechanical Analysis of Rotator Cuff Repair Utilizing the Tendon-to-Bone Seam Technique or visit the TENDON SEAM System webpage here.
Dave Snyder +1 (978) 749-1440
Smith+Nephew david.snyder@smith-nephew.com
* as compared to prior biomechanical cadaveric studies evaluating the TOE repair
** versus knotted TOE in biomechanical testing
*** after 30 cycles at 180N
† 302N, 500 cycles
Smith+Nephew is a portfolio medical technology business focused on the repair, regeneration and replacement of soft and hard tissue. We exist to restore people’s bodies and their self-belief by using technology to take the limits off living. We call this purpose ‘Life Unlimited’. Our 17,000 employees deliver this mission every day, making a difference to patients’ lives through the excellence of our product portfolio, and the invention and application of new technologies across our three global business units of Orthopaedics, Sports Medicine & ENT and Advanced Wound Management.
Founded in Hull, UK, in 1856, we now operate in around 100 countries, and generated annual sales of $6.2 billion in 2025. Smith+Nephew is a constituent of the FTSE100 (LSE:SN, NYSE:SNN). The terms ‘Group’ and ‘Smith+Nephew’ are used to refer to Smith & Nephew plc and its consolidated subsidiaries, unless the context requires otherwise.
For more information about Smith+Nephew, please visit www.smith-nephew.com and follow us on X, LinkedIn, Instagram or Facebook.
This document may contain forward-looking statements that may or may not prove accurate. For example, statements regarding expected revenue growth and trading profit margins, market trends and our product pipeline are forward-looking statements. Phrases such as "aim", "plan", "intend", "anticipate", "well-placed", "believe", "estimate", "expect", "target", "consider" and similar expressions are generally intended to identify forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and other important factors that could cause actual results to differ materially from what is expressed or implied by the statements. For Smith+Nephew, these factors include: conflicts in Europe and the Middle East, economic and financial conditions in the markets we serve, especially those affecting healthcare providers, payers and customers; price levels for established and innovative medical devices; developments in medical technology; regulatory approvals, reimbursement decisions or other government actions; product defects or recalls or other problems with quality management systems or failure to comply with related regulations; litigation relating to patent or other claims; legal and financial compliance risks and related investigative, remedial or enforcement actions; disruption to our supply chain or operations or those of our suppliers; competition for qualified personnel; strategic actions, including acquisitions and disposals, our success in performing due diligence, valuing and integrating acquired businesses; disruption that may result from transactions or other changes we make in our business plans or organisation to adapt to market developments; relationships with healthcare professionals; reliance on information technology and cybersecurity; disruptions due to natural disasters, weather and climate change related events; changes in customer and other stakeholder sustainability expectations; changes in taxation regulations; effects of foreign exchange volatility; and numerous other matters that affect us or our markets, including those of a political, economic, business, competitive or reputational nature. Please refer to the documents that Smith+Nephew has filed with the U.S. Securities and Exchange Commission under the U.S. Securities Exchange Act of 1934, as amended, including Smith+Nephew's most recent annual report on Form 20-F, which is available on the SEC’s website at www. sec.gov, for a discussion of certain of these factors. Any forward-looking statement is based on information available to Smith+Nephew as of the date of the statement. All written or oral forward-looking statements attributable to Smith+Nephew are qualified by this caution. Smith+Nephew does not undertake any obligation to update or revise any forward-looking statement to reflect any change in circumstances or in Smith+Nephew's expectations.
◊ Trademark of Smith+Nephew. Certain marks registered in US Patent and Trademark Office.